Litcius/Paper detail

mTORC2 Assembly Is Regulated by USP9X-Mediated Deubiquitination of RICTOR

Lidia Wróbel, Farah H. Siddiqi, Sandra Malmgren Hill, Sung Min Son, Cansu Karabiyik, Hyun‐Jeong Kim, David C. Rubinsztein

2020Cell Reports32 citationsDOIOpen Access PDF

Abstract

The mechanistic target of rapamycin complex 2 (mTORC2) controls cell metabolism and survival in response to environmental inputs. Dysregulation of mTORC2 signaling has been linked to diverse human diseases, including cancer and metabolic disorders, highlighting the importance of a tightly controlled mTORC2. While mTORC2 assembly is a critical determinant of its activity, the factors regulating this event are not well understood, and it is unclear whether this process is regulated by growth factors. Here, we present data, from human cell lines and mice, describing a mechanism by which growth factors regulate ubiquitin-specific protease 9X (USP9X) deubiquitinase to stimulate mTORC2 assembly and activity. USP9X removes Lys63-linked ubiquitin from RICTOR to promote its interaction with mTOR, thereby facilitating mTORC2 signaling. As mTORC2 is central for cellular homeostasis, understanding the mechanisms regulating mTORC2 activation toward its downstream targets is vital for our understanding of physiological processes and for developing new therapeutic strategies in pathology.

Topics & Concepts

Cell biologymTORC2BiologyPI3K/AKT/mTOR pathwaymTORC1Signal transductionUbiquitin and proteasome pathwaysGenetics and Neurodevelopmental DisordersPI3K/AKT/mTOR signaling in cancer
mTORC2 Assembly Is Regulated by USP9X-Mediated Deubiquitination of RICTOR | Litcius